Shares of WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) saw unusually-strong trading volume on Thursday. Approximately 7,941 shares traded hands during mid-day trading, an increase of 60% from the previous session’s volume of 4,972 shares. The stock last traded at $24.28 and had previously closed at $25.12.
Analyst Upgrades and Downgrades
Separately, Zacks Research lowered shares of WuXi AppTec from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy”.
Get Our Latest Stock Report on WUXAY
WuXi AppTec Price Performance
The firm’s fifty day moving average price is $25.79 and its two-hundred day moving average price is $20.76.
About WuXi AppTec
WuXi AppTec is a global pharmaceutical and biotechnology services company that provides contract research, development and manufacturing services. The company supports drug developers throughout the product life cycle, from early-stage discovery and laboratory testing through clinical development and commercial production.
Its offerings include medicinal and synthetic chemistry, biology research, preclinical and clinical testing, regulatory support, pharmaceutical manufacturing, and the development and manufacturing of advanced therapies.
See Also
- Five stocks we like better than WuXi AppTec
- Flywire’s Rapid Growth Faces a Q3 Test—Is Its Stock Already Too Expensive?
- Cologuard Is Working—So Why Isn’t Abbott Stock?
- Micron’s Taiwan Strike: A High-Stakes Fight Over AI Profits
- Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
